How would you explain your research?

Currently, I am looking at exploiting the use of selectins, which are cell adhesion molecules expressed during inflammation, as imaging targets to inform treatment of vascular disease. Magnetic Resonance Imaging (MRI) will play a large part in the project and will be utilised for the imaging of selectins, using iron oxide nanoparticles and DOTA complexes.

Why Nottingham and why the Precision Imaging Beacon?

I applied to Nottingham due to the multidisciplinary nature of this project, which involves chemistry, biology and medicine, as well as the excellent facilities at Nottingham and expertise at the Precision Imaging Beacon.

 

Currently, I am looking at exploiting the use of selectins, which are cell adhesion molecules expressed during inflammation, as imaging targets, to inform treatment of vascular disease.

How will your research affect the average person?

Vascular disease impacts over 30 million people a year in the US alone (Center for Disease Control and Prevention, CDC). This figure alone is indicative of the potential impact of research in these area.  Imaging research in particular would inform treatment and monitoring of vascular disease, ultimately bringing benefits to the individual and society in general.

What’s been the greatest moment of your career so far?

The highlight of my career so far has been when I was involved in the synthesis of novel antibiotic-metal complexes which proved rather challenging but very rewarding.

How will being based at UoN and joining Precision Imaging help you achieve your goals?

Being based at UoN and joining Precision Imaging Beacon will help me achieve my goals due to the unique combination of expertise and excellent facilities.

What aspects of your research and role are you looking forward to?

The ability to continuously learn and develop as a person and an academic whilst contributing to research I am genuinely interested in is very appealing to me.